2157 fundamentals
LEPU BIOPHARMA CO LTD financial statements, including revenue, expenses, and profit
The total revenue of 2157 for the last semiannual is 254.40 M HKD, and it's 76.14% higher compared to the previous semiannual. The net income of H2 24 is -237.52 M HKD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM